Lower T cell inhibitory receptor level in mononuclear cells from cord blood compared with peripheral blood.

T cell inhibitory receptors play important role in maintaining T cell homeostasis. The feature of such negative costimulator signal transduction pathway in cord blood (CB) T cells remains unclear. In this study, the expression levels of T cell inhibitory receptors including programmed death-1 (PD-1), cytotoxic T lymphocyte antigen-4 (CTLA-4), T cell immunoglobulin mucin-3 (Tim-3), lymphocyte activation gene-3 (LAG-3) and B and T lymphocyte attenuator (BTLA) were characterized in CB and compared with peripheral blood (PB). Significant lower expression of PD-1, CTLA-4, LAG-3 and BTLA was found in CB, while similar expression level of Tim-3 was showed between CB and PB. Together, different expression pattern of such T cell inhibitory receptor in CB is worthy to further discuss their role on immune response when CB is used in cord blood stem cell transplantation as well as allogeneic chimeric antigen receptor T-cell producing.

[1]  Shaohua Chen,et al.  Different aberrant expression pattern of immune checkpoint receptors in patients with PTCL and NK/T‐CL , 2018, Asia-Pacific journal of clinical oncology.

[2]  Alaina Kaiser,et al.  Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL. , 2018, Blood.

[3]  Shaohua Chen,et al.  Increased exhausted CD8+ T cells with programmed death‐1, T‐cell immunoglobulin and mucin‐domain‐containing‐3 phenotype in patients with multiple myeloma , 2018, Asia-Pacific journal of clinical oncology.

[4]  S. Tasian.  Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled? , 2018, Therapeutic advances in hematology.

[5]  G. Borthakur,et al.  Checkpoint inhibitors and acute myelogenous leukemia: promises and challenges , 2018, Expert review of hematology.

[6]  He Huang,et al.  The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology , 2018, Journal of Hematology & Oncology.

[7]  Xuejun Li,et al.  Engineering chimeric antigen receptor-T cells for cancer treatment , 2018, Molecular Cancer.

[8]  J. Orange,et al.  Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity , 2018, Leukemia.

[9]  Shaohua Chen,et al.  Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia. , 2017, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[10]  Shaohua Chen,et al.  Re-balance of memory T cell subsets in peripheral blood from patients with CML after TKI treatment , 2017, Oncotarget.

[11]  Zhiqiang Yan,et al.  Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia , 2017, Journal of Hematology & Oncology.

[12]  S. Katz,et al.  Frontline Science: Functionally impaired geriatric CAR‐T cells rescued by increased α5β1 integrin expression , 2017, Journal of leukocyte biology.

[13]  M. Subklewe,et al.  Recent developments in immunotherapy of acute myeloid leukemia , 2017, Journal of Hematology & Oncology.

[14]  He Huang,et al.  Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia , 2017, Experimental Hematology & Oncology.

[15]  T. Duong,et al.  Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular function , 2017, Stem Cell Research & Therapy.

[16]  B. Palmer,et al.  Programmed Death 1 Expression on CD4+ T Cells Predicts Mortality after Allogeneic Stem Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  Yang Feng,et al.  Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition. , 2016, The Journal of clinical investigation.

[18]  K. Rezvani,et al.  A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells. , 2016, Cytotherapy.

[19]  Shaohua Chen,et al.  Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP , 2016, Hematology.

[20]  P. Moss,et al.  Cord Blood T Cells Retain Early Differentiation Phenotype Suitable for Immunotherapy After TCR Gene Transfer to Confer EBV Specificity , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  M. Duval,et al.  CD8(+) T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse. , 2011, Blood.

[22]  Shaohua Chen,et al.  TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T-cells. , 2007, Transplant immunology.

[23]  J. Rodríguez-Sánchez,et al.  Naive CD4+ Cells from Cord Blood Can Generate Competent Th Effector Cells , 2005, Transplantation.

[24]  S. Shurin,et al.  Reduced CTLA-4 protein and messenger RNA expression in umbilical cord blood T lymphocytes. , 2002, Experimental hematology.